Acute and chronic effects of sulfur mustard on the skin: A comprehensive review

Cutaneous and Ocular Toxicology

Volumn 29, Issue 4, 2010, Pages 269-277

  Ghanei, Mostafa ^a   Poursaleh, Zohreh ^a   Harandi, Ali Amini ^c   Emadi, Seyed Emad ^d   Emadi, Seyed Naser ^a,b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Institute of Applied Science and Technology   (Iran)

Author keywords

Carcinogenicity; Dermatitis; Skin; Sulfur mustard; Treatment

Indexed keywords

MUSTARD GAS;

ACUTE TOXICITY; ARTICLE; CARCINOGENICITY; CHEMICAL WARFARE; CHRONIC TOXICITY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; LONG TERM EXPOSURE; MEDLINE; MOLECULAR MECHANICS; NONHUMAN; PRURITUS; SKIN BURNING SENSATION; SKIN TOXICITY; SWINE;

ACUTE DISEASE; ANIMALS; AUTOIMMUNE DISEASES; CHEMICAL WARFARE AGENTS; CHRONIC DISEASE; CORNEA; HUMANS; MUCOUS MEMBRANE; MUSTARD GAS; PUBMED; SKIN; SKIN DISEASES;

EID: 78049374472     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2010.511367     Document Type: Article

References (82)

1. Evison D, Hinsley D, Rice P. Chemical weapons [review]. Br Med J. 2002; 324(7333):332-335
2. Wattana M, Bey T. Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat. Prehosp Disaster Med 2009; 24(1):19-29; discussion 30-31.
3. Balali-Mood M, Balali-Mood B. Sulphur mustard poisoning and its complications in Iranian veterans. Iran J Med Sci 2009;34(3):155-171.
4. Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. Sulfur mustard: its continuing threat as a chemical warfare agent,the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health efects, and new developments for protection and therapy. J Am Acad Dermatol 1995; 32(5 pt 1):765-776.
5. Balali-Mood M, Hefazi M. Te pharmacology, toxicology, and medical treatment of sulphur mustard poisoning [review].Fundam Clin Pharmacol 2005; 19(3):297-315.
6. Momeni AZ, Enshaeih S, Meghdadi M, Aminjavaheri M.Skin manifestation of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992;128(6):775-780.
7. Smith KJ. Te prevention and treatment of cutaneous injury secondary to chemical warfare agents. Application of these fnding to other dermatologic conditions and wound healing. Dermatol Clin 1999; 17(1):41-60.
8. Borak J, Sidell F. Agents of chemical warfare: sulfur mustard.Ann Emerg Med 1992; 21:303-308.
9. Smith KJ, Casillas R, Graham J, Skelton HG, Stemler F, Hackley BE Jr. Histopathologic features seen with diferent animal models following cutaneous sulfur mustard exposure. J Dermatol Sci 1997; 14(2):126-135.
10. Smith W, Dunn MA. Medical defence against blistering chemical warfare agents. Arch Dermatol.1991;127:1207-13.
11. Pechura CM, Rall DP. In: Veterans at Risk: Te Health Efects of Mustard Gas and Lewisite; Washington, DC: Institute of Medicine, National Academies Press. 1993.
12. Naraghi ZS, Mansouri P, Mortazavi M. A clinicopathological study on acute cutaneous lesions induced by sulfur mustard gas (yperite). Eur J Dermatol 2005; 15(3):140-145.
13. Balali-Mood M, Hefazi M. Comparison of early and late toxic efects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006; 99(4):273-282.
14. Namazi S, Niknahad H, Razmkhah H. Long-term complications of sulphur mustard poisoning in intoxicated Iranian veterans. J Med Toxicol 2009; 5(4):191-195.
15. Renshaw B. Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In: Chemical Warfare Agents, and Related Chemical Problems-Parts III-VI. Summary technical report of Division 9.Washington, DC: National Defense Research Committee of the Ofce of Scientifc Research and Development; 1946.
16. Willems JL. Clinical management of mustard gas casualties.Ann Med Militaris Belgicae 1989; (Suppl.): 1-60.
17. Pirie A. Te action of mustard gas on collagen. Biochem. J. 1947;41, 185.
18. Mellor SG, Rice P, Cooper GJ. Vesicant burns. Br J Plast Surg 1991; 44(6):434-437.
19. Alexander SF. Medical report of the Bari Harbor mustard casualties.Mil. Surg 1947; 101, 1-20.
20. Sidell FR, Takafuji ET, Franz DR. Vesicants. In: Zajtchuk R,Bellamy RF, eds. Medical Aspects of Chemical and Biologica Warfare; Washington, DC: Ofce of the Surgeon General at TMM Publications, Borden Institute, Walter Reed Army Medical Center. 1997:197-228.
21. Emadi SN, Hosseini-Khalili A, Soroush M, Ardakani MK,Ghassemi-Broumand M, Davoodi SM, et al. External ure-thral stenosis: a latent efect of sulfur mustard two decades postexposure.Int J Dermatol 2009; 48(9):960-963.
22. Graham JS, Stevenson RS, Mitcheltree LW, Hamilton TA, Deckert RR, Lee RB, et al. Medical management of cutaneous sulfur mustard injuries. Toxicology 2009;263(1):47-58.
23. Emadi SN, Mortazavi M, Mortazavi H. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a long-term investigation. Arch Dermatol 2008; 144(8):1059-1061.
24. Panahi Y, Davoodi SM, Khalili H, Dashti-Khavidaki S, Bigdeli M. Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure. Singapore Med J 2007; 48(5):392-395.
25. Shohrati M, Peyman M, Peyman A, Davoudi M, Ghanei M.Cutaneous and ocular late complications of sulfur mustard in Iranian veterans [review]. Cutan Ocul Toxicol 2007; 26(2):73-81.
26. Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int J Dermatol 2006;45(9):1025- 1031.
27. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D.Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003; 45(11):1136-1143.
28. Firooz A, Komeili A, Dowlati Y. Eruptive melanocytic nevi and cherry angiomas secondary to exposure to sulfur mustard gas. J Am Acad Dermatol 1999; 40(4):646-647.
29. Fekri AR, Janghornbani M. Late dermal complications in Iranian veterans. In: Proceedings of the Seminar on Late Complications of Chemical Warfare Agents in Iranian Veterans; Tehran, Iran: Tehran University Press. 1992:57-89.
30. Davoudi SM, Sadr B, Hayatbakhsh MR, Keshavarz S, Shohrati M, Naghizadeh MM, et al. Comparative study of skin sebum and elasticity level in patients with sulfur mustard-induced dermatitis and healthy controls. Skin Res Technol 2010;16(2):237-242.
31. Emadi SN, Hosseini-Khalili A, Soroush MR, Davoodi SM,Aghamiri SS. Mustard gas scarring with specifc pigmentary,trophic and vascular characteristics (case report, 16-year post-exposure). Ecotoxicol Environ Saf 2008; 69(3):574-576. Epub 2007 Mar 26.
32. Lei Z, Wen C, Xu J, Li X, Qing L, Wei M. OxLDL upregu-lates growth-regulation oncogene alpha expression in human endothelial cells. Chin Med J (Engl). 2001 Dec;114(12):1240-4.
33. Sayer NM, Whiting R, Green AC, Anderson K, Jenner J,Lindsay CD. Direct binding of sulfur mustard and chloroethyl ethyl sulphide to human cell membrane-associated proteins; implications for sulfur mustard pathology. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878(17-18):1426-1432.
34. Tsuruta J, Sugisaki K, Dannenberg AM Jr, Yoshimura T, Abe Y, Mounts P. Te cytokines NAP-1 (IL-8), MCP-1, IL-1 beta,and GRO in rabbit infammatory skin lesions produced by the chemical irritant sulfur mustard. Infammation 1996;20(3):293-318.
35. Ricketts KM, Santai CT, France JA, Graziosi AM, Doyel TD,Gazaway MY, et al. nfammatory cytokine response in sulfur mustard-exposed mouse skin. J Appl Toxicol 2000; 20 (suppl 1):S73-S76.
36. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning.Toxicology 2005; 214(3):198-209.
37. Sabourin CL, Danne MM, Buxton KL, Casillas RP, Schlager JJ.Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002; 16(6):263-272.
38. Sabourin CL, Danne MM, Buxton K, Rogers JV, Niemuth NA, Blank JA, et al. Modulation of sulfur mustard-induced infam-mation and gene expression by Olvanil in the hairless mouse vesicant model. Cutan Ocul Toxicol 2003;22(3):125-136.
39. Arroyo CM, Schafer RJ, Kurt EM, Broomfeld CA, Carmichael AJ. Response of normal human keratinocytes to sulfur mustard: cytokine release. J Appl Toxicol 2000; 20(suppl 1):S63-S72.
40. Wormser U, Brodsky B, Proscura E, Foley JF, Jones T, Nyska A. Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion; efect of topical iodine. Arch Toxicol 2005; 79(11):660-670.
41. Shakarjian MP, Heck DE, Gray JP, Sinko PJ, Gordon MK,Casillas RP, et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 2010; 114(1):5-19.
42. Gerecke DR, Chen M, Isukapalli SS, Gordon MK, Chang YC, Tong W, et al. Diferential gene expression profling of mouse skin after sulfur mustard exposure: extended time response and inhibitor efect. Toxicol Appl Pharmacol 2009;234(2):156-165.
43. Paromov V, Suntres Z, Smith M, Stone WL. Sulfur mustard tox-icity following dermal exposure: role of oxidative stress,and antioxidant therapy. J Burns Wounds 2007;7:e7.
44. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications; Boca Raton, FL: CRC Press.1991:43-78.
45. Smith KJ, Graham JS, Hamilton TA, Skelton HG, Petrali JP,Hurst CG.Immunohistochemical markers for basement membrane proteins and proliferation and apoptosis markers in sulfur mustard induced cutaneous lesions in weanling pigs. J Dermatol Sci 1997; 15 (3):173-182.
46. Sidell FR, Hurst CG. Long-term health efects of nerve agents and mustard.Warfare, Weaponry and the Casualty-Medical Aspects of Chemical and Biological Warfare. Ofce of the Surgeon General at TMM Publications Borden Institute, Walter Reed Army Medical Center, Washington, DC.1997: 229-246. http://www.globalsecurity.org/wmd/library/report/1997/cwbw/Ch8.pdf. Accessed January 15, 2006.
47. Novick M, Gard DA, Hardy SB, Spira M. Burn scar carcinoma:a review and analysis of 46 cases. J Trauma 1977;17(10):809-817.
48. Treves N, Pack GT. Development of cancer in burn scars:analysis and report of 34 cases. Surg Gynecol Obstet 1930;51:749-782.
49. Inada S, Hiragun K, Seo K, Yamura T. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan, with special reference to mustard gas exposure. J Dermatol. 1978 Apr;5(2):49-60.
50. Balali-Mood M, Mousavi SH, Balali-Mood B. Chronic health efects of sulphur mustard exposure with special reference to Iranian veterans. Emerg Heal Treats J 2008; 1:e7.
51. Chiesman WE. Diagnosis and treatment of lesions due to vesicants. Br Med J 1944; 2:109-112.
52. McManus J, Huebner K. Vesicants. Crit Care Clin. 2005 Oct;21(4):707-718, vi.
53. Newmark J, Langer JM, Capacio B, Barr J, McIntosh RG. Liquid sulfur mustard exposure. Mil Med. 2007 Feb;172(2):196-198.
54. Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol. 2006 Jan;31(1):1-5. Review.
55. Sidell FR. Chemical warfare agents. In: Viccellio P (ed).Emergency Toxicology; Philadelphia, PA: Lippicott-Raven Publishers. 1988:255-266.
56. Marrs TC, Maynard RL, Sidell FR. Chemical Warfare Agents:Toxicology and Treatment; Chichester, UK: John Wiley and Sons. 1996.
57. Graham JS, Gerlach TW, Logan TP, Bonar JP, Fugo RJ, Lee RB,et al. Methods of advanced wound management for care of combined traumatic and chemical warfare injuries. Eplasty 2008;8:e34.
58. Graham JS, Chilcott RP, Rice P, Milner SM, Hurst CG, Maliner BI. Wound healing of cutaneous sulfur mustard injuries:strategies for the development of improved therapies. J Burns Wounds 2005;4:e1.
59. Rice P, Brown RF, Lam DG, Chilcott RP, Bennett NJ.Dermabrasion: a novel concept in the surgical management of sulphur mustard injuries. Burns 2000; 26(1):34-40.
60. Eldad A, Weinberg A, Breiterman S, Chaouat M, Palanker D, Ben-Bassat H. Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns. Burns 1998;24(2):166-172.
61. Greenberg S, Kamath P, Petrali J, Hamilton T, Garfeld J,Garlick JA. Characterization of the initial response of engineered human skin to sulfur mustard. Toxicol Sci 2006;90(2):549-557.
62. Monteiro-Riviere NA, Inman AO, Babin MC, Casillas RP.Immunohistochemical characterization of the basement membrane epitopes in bis(2-chloroethyl) sulfde-induced toxicity in mouse ear skin. J Appl Toxicol 1999; 19(5):313-328.
63. Pal A, Tewari-Singh N, Gu M, Agarwal C, Huang J, Day BJ, White CW, Agarwal R. Sulfur mustard analog induces oxida-tive stress and activates signaling cascades in the skin of SKH-1 hairless mice.Free Radic Biol Med 2009; 47(11):1640-1651.
64. Tewari-Singh N, Rana S, Gu M, Pal A, Orlicky DJ, White CW, Agarwal R. Infammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfde-induced skin injury in SKH-1 hairless mice. Toxicol Sci. 2009;108(1):194-206.
65. Gould NS, White CW, Day BJ. A role for mitochondrial oxi-dative stress in sulfur mustard analog 2-chloroethyl ethyl sulfde-induced lung cell injury and antioxidant protection.J Pharmacol Exp Ter 2009; 328(3):732-739.
66. Chilcott R P, Jenner J, Hotchkiss SA, Rice P. In vitro skin absorption and decontamination of sulphur mustard: comparison of human and pig-ear skin. J Appl Toxicol 2001; 21(4):279-283.
67. Arroyo CM, Burman DL, Kahler DW, Nelson MR, Corun CM,Guzman JJ, et al. TNF-alpha expression patterns as potential molecular biomarker for human skin cells exposed to vesicant chemical warfare agents: sulfur mustard (HD) and Lewisite (L). Cell Biol Toxicol 2004; 20(6):345-359.
68. Arroyo CM, Kan RK, Burman DL, Kahler DW, Nelson MR,Corun CM, et al. Regulation of 1-a, 25-dihydroxyvitamin D3 on inter-leukin-6 and interleukin-8 induced by sulfur mustard
69. Davoudi SM, Keshavarz S, Sadr B, Shohrati M, Naghizadeh MM, Farsinejad K, et al, Skin hydration and transepidermal water loss in patients with a history of sulfur mustard contact: a case-control study. J Eur Acad Dermatol Venereol. 2009 Aug;23(8):940-944
70. Hattersley IJ, Jenner J, Dalton C, Chilcott RP, Graham JS.Te skin reservoir of sulphur mustard. Toxicol In Vitro 2008;22(6):1539-1546.
71. Heinrich A, Balszuweit F, Tiermann H, Kehe K. Rapid simultaneous determination of apoptosis, necrosis, and viability in sulfur mustard exposed HaCaT cell cultures. Toxicol Lett 2009; 191(2-3):260-267.
72. Ishida H, Ray R, Ray P. Sulfur mustard downregulates iNOS expression to inhibit wound healing in a human keratinocyte model. J Dermatol Sci 2008; 49(3):207-216.
73. Sawyer TW, Nelson P. Hypothermia as an adjunct therapy to vesicant-induced skin injury. Eplasty 2008; 8:e25.
74. Shahin S, Cullinane C, Gray PJ. Mitochondrial and nuclear DNA damage induced by sulphur mustard in keratinocytes.Chem Biol Interact 2001; 138(3):231-245.
75. Smith KJ, Smith WJ, Hamilton TA, Skelton HG, Graham JS, Okerberg C, Moeller R, Hackley BE Jr. Histopathologic and Immunohistochemical Features in Human Skin after Exposure to Nitrogen and Sulfur Mustard. Am J Dermatopathol 1998;20:22-28.
76. Ghassemi-Broumand M, Aslani J, Emadi SN. Delayed ocular, pulmonary, and cutaneous complications of mustards in patients in the city of Sardasht, Iran. Cutan Ocul Toxicol 2008; 27(4):295-305.
77. Black AT, Joseph LB, Casillas RP, Heck DE, Gerecke DR, Sinko PJ, et al. Role of MAP kinases in regulating expression of anti-oxidants and infammatory mediators in mouse keratinocytes following exposure to the half mustard, 2-chloroethyl ethyl sulfde. Toxicol Appl Pharmacol 2010; 245(3):352-360.
78. Dillman JF, Hege AI, Phillips CS, Orzolek LD, Sylvester AJ, Bossone C, et al. Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfde: gene expression pro-fles correlate with treatment efcacy and an established clinical endpoint.J Pharmacol Exp Ter 2006; 317(1):76-87. Epub 2005 Dec 23.
79. Gerecke DR, Sabourin CLK, Bhatt P, Rudge TL Jr, Casillas R P, Kiser RC, et al. Laminin 5 and gelatinase alterations in mouse skin following sulfur mustard (SM). Proc Biosci Rev 2004; 211:1-12.
80. Margulis A, Chaouat M, Ben-Bassat H, Eldad A, Icekson M,Breiterman S, Neuman R. Comparison of topical iodine and silver sulfadiazine as therapies against sulfur mustard burns in a pig model. Wound Repair Regen 2007; 15(6):916-921.
81. Taysse L, Dorandeu F, Daulon S, Foquin A, Perrier N, Lallement G, et al. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse. (II) Efects of some currently used skin decontaminants (RSDL and Fulleras earth) against liquid sulphur mustard and VX exposures. Hum Exp Toxicol. 2010 Jun 9.
82. Wormser U, Sintov A, Brodsky B, Casillas RP, Nyska A. A protective efect of topical iodine containing anti-infammatory drugs against sulfur mustard-induced skin lesions. Arch Toxicol 2004; 78(3):156-166.